AI-generated summary
This case report describes one patient with facial paralysis of 8 years who received photobiomodulation with low-level laser at 660 and 808 nm, three times weekly for 8 weeks. The authors report improvements on the House-Brackmann scale and electroneuromyography during and at the end of treatment, and conclude the approach was effective and noninvasive for this patient.
- Who or what was studied
- One patient with facial paralysis of 8 years duration
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- The abstract describes a single case with no control group, so the findings cannot be generalized to other patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Case report, Photobiomodulation therapy, Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.